Tag: news

  • U.S. Army Article Wrongly Places EVALI Cause on E-Cigs

    U.S. Army Article Wrongly Places EVALI Cause on E-Cigs

    Credit: Media VN

    It doesn’t stop. Since the U.S. Centers for Disease Control and Prevention and U.S. Food and Drug Administration wrongly blamed nicotine vaping products as the cause of e-cigarette or vaping use-associated lung injury (EVALI) numerous news outlets continue to spread the misinformation.

    The official website for the U.S. Army yesterday published an article wrongly blaming EVALI on nicotine vaping products. The article states that “vaping has been commercially available since the early 2000s, and there have been hundreds of reports” of EVALI since then. “Public Health officials advise against the use of e-cigarettes, but highly recommend purchase from known vendors, if consuming … Washington says an estimated 200,000–300,000 active duty service members are diagnosed with acute respiratory issues annually.”

    After the CDC announced that vitamin E acetate in black market marijuana vaping products was the cause EVALI more than two years ago, many media outlets continue to falsely blame nicotine vaping products for the lung illness that was first identified in 2019.

    Credit: Master1305

    A study published in January 2020 in the journal Toxics provided important insight into the lung intoxication epidemic. The study presented, for the first time, a comprehensive analysis of products used by EVALI patients. Vitamin E acetate was the main finding in cannabinoid liquids. No compound that could be linked to EVALI was found in the two nicotine products tested.

    Some tobacco control experts said the CDC created panic with its refusal to directly blame the actual causes of EVALI, vitamin E acetate in illegal THC vapes. Following CDC’s lead, state health departments spread the word that using an e-cigarette to quit smoking could be life-threatening — so much so that seven states issued emergency bans on the sale of most or all electronic cigarettes.

    “Throughout its investigation of the first outbreak, CDC created public hysteria over the dangers of electronic cigarettes by attributing the outbreak to all vaping products, whether they contained nicotine or THC and whether they were purchased at a highly regulated vape shop or from a drug dealer on the street,” wrote Michael Siegel, a professor in the Department of Community Health Sciences, Boston University School of Public Health, where he has conducted research on tobacco for 25 years, at the time. “The very name that CDC attached to the outbreak directly implicated electronic cigarettes, which are nicotine-delivery devices that are effective in helping adult smokers to quit smoking. Following CDC’s lead, state health departments spread the word that using an e-cigarette to quit smoking could be life-threatening — so much so that seven states issued emergency bans on the sale of most or all electronic cigarettes.”

  • Califf Confirmation as New FDA Chief Expected Today

    Califf Confirmation as New FDA Chief Expected Today

    The FDA is expected to have a new leader today. Robert Califf will likely be confirmed as the next commissioner of the U.S. Food & Drug Administration (FDA) by midday Tuesday.

    On Monday night, the Senate voted 49-45 to advance his nomination as part of a cloture vote, a key procedural hurdle that can also show whether or not Senate leadership has enough votes to succeed. Technically, cloture simply streamlines the vote by limiting down the time a matter can be discussed and also restricting Senators from certain actions such as amendments that are unrelated to the vote.

    Robert Califf / Credit: Modern Healthcare

    While this vote was close—five Republicans and one Democrat did not vote—Senate leadership typically does not call for cloture unless it believes it has the votes to pass a measure, writes Charlie Minato, an editor with Halfwheel.

    He garnered the support of five Republicans, while simultaneously having five members of the Democratic caucus vote against his nomination. 

    The five had opposed him due to concerns over his close to ties to the pharmaceutical industry and FDA’s lack of action(s) regarding the opioid crisis. According to an article in The New York Times, abortion foes also are urging Republican lawmakers to reject Califf, who previously led the agency during the final year of the Obama administration.

  • Australia: More than $2 Million Worth of Vape Pens Seized

    Australia: More than $2 Million Worth of Vape Pens Seized

    Credit: Belyay

    Australian authorities have seized tens of thousands of nicotine vapes illegally being sold in the country over the past 18 months. Between July 2020 and December 2021, the New South Wales Department of Health seized more than 100,000 illegal vaping products, with a street value of more than $2 million.

    Since October, Australian vapers have been required to obtain a doctor’s prescription for nicotine-containing e-cigarettes and liquids. Doctors are supposed to prescribe the products only as a last resort when more proven quit treatments fail. The law changes were prompted by concerns about the health impacts of vaping, and data showing children are increasingly using the products.

    Over the past year, local public health units had been springing convenience stores, petrol stations and tobacconists who were selling vapes to children, enlisting undercover teenagers to attempt to purchase the products, according to news reports.

    Consumers who fail to include a nicotine prescription with their order will be subject to a fine of up to $222,000. The new system will work if enough doctors, pharmacists, smokers and vapers are willing to comply and are provided with sufficient information.

  • New Zealand: New Vapor Packaging Rules Go Into Effect

    New Zealand: New Vapor Packaging Rules Go Into Effect

    New Zealand flag on boat
    Credit: govt.nz

    Thousands of vaping products in New Zealand started being removed from store shelves Friday as new regulations on packaging come into effect.

    The move is part of the amended Smokefree Vaping Act rolled out 15 months ago, which includes it only being legal to sell vape products registered with the Ministry of Health, according to 1News.

    Action for Smokefree 2025 director Deborah Hart on Friday told Breakfast the new regulations mean manufacturers need to be more transparent about what’s in their products.

    “The Government has been rolling out regulations right from the very start of the (Smokefree Environments and Regulated Products) Act. So from the start of the Act until today, one of the things we’ve been doing is around the safety of the product,” she said.

    “Six months ago importers and manufacturers had to start notifying what was in their products – had to notify labels, packaging and what’s in the products.

    “And today they had to do all that, they can only sell what’s been notified, and to notify they had to adhere to the safety regime that had been set up by the Government. So that’s fantastic.”

  • Vapor, Oral Products Continue to Boost BAT Sales

    Vapor, Oral Products Continue to Boost BAT Sales

    A seven percent rise in full-year adjusted revenue to 25.7 billion pounds ($34.8 billion) was reported by BAT Friday, helped by sales of e-cigarettes and oral nicotine.

    The world’s second-largest tobacco company also announced a dividend increase of 1.0 percent to 217.8 pence and a 2 billion pound share repurchase program for 2022, according to Reuters.

    It posted a 51 percent rise to 2.05 billion pounds in adjusted sales of its “new categories” product line which includes e-cigarettes, heated tobacco and oral nicotine. Though the division has yet to turn a profit, BAT said it was on track to report revenue of 5 billion pounds and profitability by 2025.

    “Continued growth in new categories is a cornerstone of BAT’s long-term plans for success,” Third Bridge analyst Ross Hindle said. “With over 1.1 billion smokers still using combustibles, the opportunity to convert consumers towards New Categories is highly attractive.”

    The company said 4.8 million more consumers than last year used non-combustible products such as Vuse e-cigarettes, glo heated tobacco and Velo oral nicotine.

  • Activists Welcome Thailand’s Plan to Legalize Vaping

    Activists Welcome Thailand’s Plan to Legalize Vaping

    Asa Saligupta

    Tobacco harm reduction advocates have welcomed Thailand’s plans to legalize and regulate vapor products.

    “Countries which have chosen to legalize and regulate e-cigarettes have seen a fall in overall smoking rates and have much better control over youth vaping. It’s exciting for Thailand, and in fact the world, that the government is now set to overturn its ban on the sale of vape products,” says Asa Saligupta, director of ENDS Cigarette Smoke Thailand (ECST).

    According to Saligupta, Thailand’s harsh ban and penalties on vape sales has meant too many smokers have been stuck with cigarettes, while young people buy e-cigarettes in the underground economy with no control over the purchase age or product safety standards.

    “We’ve seen the legalization and regulation of vaping in places like the United States, United Kingdom and New Zealand work very well. I’m delighted the Thai government is now listening to the science with the adoption of effective tobacco harm reduction (THR) policies now increasingly imminent,” he says.

    The ECST director says Digital Economy and Society Minister Chaiwut Thanakamanusorn, government officials, public health experts and advocates have all been key to finally addressing Thailand’s failed tobacco control policies.

    He says that, despite the minister adopting an evidence-based approach, local conservative health groups continue to unfairly target him and publicly scaremonger.

    “It was a big breakthrough last year when the minister told local media that vaping is safer for people trying to quit smoking. Since then, he has walked the talk—looking at ways vaping can be legalized. He fully understands it offers smokers a less harmful alternative to deadly cigarettes and protects non-smokers from the dangers of second-hand smoke.

    “Consumer groups like ours have worked hard to encourage our politicians and officials to follow the significant international public health evidence. It has been a long journey, but we’re pleased with the progress the government’s working group continues to make on legalizing e-cigarette sales,” says Saligupta.

    Nancy Loucas

    International research also shows countries which have adopted progressive policies around vaping have seen their smoking rates fall twice as fast as those countries that haven’t.

    Nancy Loucas, executive coordinator of The Coalition of Asia Pacific Tobacco Harm Advocates (CAPHRA), says that by lifting its long ban on vape sales, Thailand will join about 70 countries that have legalized vaping.

    “Around the world, vaping is saving millions of ex-smokers’ lives and can save many more if safer nicotine products are embraced, not demonized,” says Loucas. “Thailand’s 10 million smokers have long deserved a readily and legally available alternative to cigarettes. The country’s sky-high smoking rate is totally unacceptable but thanks to the work of ECST and others, it’s about to be seriously addressed.”

    According to Loucas, Thailand has become increasingly isolated internationally with its harsh policies. Vapers currently risk arrests, sanctions and even imprisonment.

    “By legalizing that sale of vapes, Thailand will join countries like the Philippines and Malaysia which are also waking up to the fact that vaping bans inevitably fail, leading to unnecessary smoking-related illnesses and deaths,” says Loucas.

  • Geek Bar Launches Shisha Vapes for U.K. Market

    Geek Bar Launches Shisha Vapes for U.K. Market

    Photo: Geek Bar

    Geek Bar is launching its first range of shisha vapes, which will be widely available across the U.K.

    The Geek Bar shisha vape includes 575 puffs and uses the same battery technology as previous Geek Bar products. The range, which comes with 2 ml e-liquid capacity and contains 20 mg/ml nicotine to comply with U.K. regulations, is available in a number of flavors, including Watermelon Berries Shisha, Hawaii Sunshine Shisha and Pineapple Guava Shisha.

    The fruit flavored range is designed to help adult smokers quit conventional cigarettes. A study conducted by Nicotine & Tobacco Research last year highlighted that vaping sweet flavors associated with fruits were more likely to help an adult smoker give up their habit than use of tobacco flavored e-liquid, according to Geek Bar.

    “Shisha pipes have become increasingly popular in the U.K., and we wanted to give those who smoke them a safer option just like we do for conventional cigarette users with a range of disposable vape products which have been a phenomenal success in the U.K.,” said Geek Bar CEO Allen Yang.

    “Due to the popularity of Geek Bar in the U.K., we’re delighted to add this new shisha range to our product offering. We are plugging an important gap in the market which will support improved public health in the U.K.”

    The new shisha range will use Geek Bar’s new packaging which will allow both retailers and consumers to check the authenticity of the product from a compliance perspective as well as make it clear that the product is for sale to only over 18-year-olds.

  • RELX Registers its Clinical Research on Vaping in China

    RELX Registers its Clinical Research on Vaping in China

    Photo: RELX

    RELX has initiated China’s first clinical research on vaping safety. The company is studying the acute effects of traditional cigarettes and electronic cigarettes on the human respiratory system and cardiovascular system. This month, RELX registered its clinical research with the China Clinical Trial Registry, a primary registry in the World Health Organization Registry Network.

    In a press release, REXL took the opportunity to highlight its commitment to cross-disciplinary fundamental research into atomization mechanisms, so as to explore the long-term health effects of vaping.

    In March 2021, RELX conducted clinical research on the metabolism and kinetics of nicotine. In both clinical studies, RELX used the vaping devices made by its strategic partner Smoore.

    Moreover, in September 2021, RELX and Smoore took the lead in drafting two industry standards “General Technical Specifications for Electronic Atomization Devices” and “Safety Technical Specifications for E-liquid”, led by the Electronic Cigarette Industry Committee of China Electronic Chamber of Commerce.

    In October 2020, the National Natural Science Foundation of China approved a research program on vaping harm reduction jointly conducted by Smoore and Tongji University. Over the next few years, Smoore and Tongji University will continue to conduct a series of studies on the health effects of vaping.

    In January, Smoore launched the world’s thinnest ceramic coil vape pod solution—FEELM Air—in London. Compared with last generation, FEELM Air boasts an overall harm reduction performance improvement of 80 percent.

    On Dec. 2, 2021, China’s State Tobacco Monopoly Administration issued the draft rules governing e-cigarettes following the regulator’s release of the exposure draft of national standards of e-cigarettes on Nov. 30, 2021.

    As China’s national standards of e-cigarettes come into effective, RELX said it will continue to increase its R&D investment and examine the harm reduction of vaping via scientific substantiation.

  • Hawaii Bill to Ban Flavors, Synthetics Moves Forward

    Hawaii Bill to Ban Flavors, Synthetics Moves Forward

    Credit: 5m3photos

    A bill in Hawaii’s House of Representatives (HB 1570) proposes to prohibit the sale of flavored tobacco and synthetic nicotine products. HB 1570 would also prohibit companies from mislabeling e-liquid products as nicotine-free and marketing electronic smoking devices to appeal to anyone under the age of 21. 

    Retailers who violate the proposed rule would face a $500 fine for a first offense and between $500 and $2,000 for a second violation, according to KITV.

    Anyone under the age of 21 in possession of a synthetic nicotine product or electronic smoking device would be fined $10 for a first offense. Any repeats would cost $50 or between 48 and 72 hours of community service.

    After Thursday’s hearing, lawmakers advanced and amended the bill to include quarterly meetings between the Department of Health and students across all schools on the matter. Establishing a vape and e-cigarette take-back program at high school and intermediate campuses statewide was also added to the measure.

    HB 1570 faces several other hearings and readings in the house.

  • PMI to Bypass Import Ban by Manufacturing IQOS in U.S.

    PMI to Bypass Import Ban by Manufacturing IQOS in U.S.

    Philip Morris International plans to manufacture IQOS in the United States to get its tobacco-heating device back on that country’s store shelves, reports Bloomberg.

    The move follows an adverse ruling against the company and its U.S. partner, Altria Group, in a patent dispute with British American Tobacco.

    In September 2021, the International Trade Commission (ITC) upheld an initial determination from May 2021 that IQOS infringes on two patents owned by BAT subsidiary Reynolds American Inc. (RAI).

    The ITC instituted an import ban and issued a cease-and-desist order, barring Altria Group from importing PMI’s IQOS 2.4, IQOS 3, IQOS 3 Duo products into the U.S. By declining to intervene, the U.S. Trade Representative upheld the ITC finding in November, leaving PMI with the options to produce IQOS domestically or tweak the design.

    A design change, however, would require authorization from the U.S. Food and Drug Administration again.

    In an interview with Bloomberg, PMI CEO Jacek Olczak, said the company had planned to manufacture IQOS in the U.S. all along. “From the very beginning of us going to the FDA, we had in mind that IQOS would one day not only be sold in the U.S., but manufactured there, if you take into consideration the size of the market and the opportunity for IQOS,” he said. “It’s just happening sooner because of the ITC decision.”

    In July 2020, the FDA authorized PMI and Altria to market IQOS with certain modified-exposure claims, giving the company a leg up over its rivals.

    PMI has not specified where it will be manufacturing IQOS but said it plans to sell IQOS in the U.S. again in the first half of 2023.